目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Primary sources
2.1.2.3 Breakdown of primaries
FIGURE 2 MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION (2022)
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 5 KEY INDUSTRY INSIGHTS
FIGURE 6 MARKET: CAGR PROJECTION (2023-2028)
FIGURE 7 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 9 STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MARKET, BY TEST TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 48)
4.1 STERILITY TESTING MARKET OVERVIEW
FIGURE 14 RISING EXPANSION OF PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO FUEL UPTAKE OF STERILITY TESTING SERVICES
4.2 ASIA: MARKET, BY PRODUCT & COUNTRY (2022)
FIGURE 15 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA
4.3 MARKET, BY REGION (2022)
FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 STERILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising expansion of pharmaceutical & biopharmaceutical production capacities
5.2.1.2 Increasing development of novel biopharmaceutical products
TABLE 2 NOVEL DRUG APPROVALS (2022)
5.2.1.3 Rising investments in life sciences research
5.2.2 RESTRAINTS
5.2.2.1 Growing adoption of single-use technology
5.2.2.2 Stringent regulatory guidelines for product approval
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Increasing outsourcing of services to sterility testing providers
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals
5.3 TARIF AND REGULATION
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT FROM NEW ENTRANTS
5.4.2 THREAT FROM SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 18 MARKET: SUPPLY CHAIN ANALYSIS
5.6 TECHNOLOGICAL ANALYSIS
5.7 INDICATIVE PRICING
TABLE 8 SELLING PRICE OF STERILITY TESTING PRODUCTS
5.8 PATENT ANALYSIS
FIGURE 19 MARKET: PATENT TESTING APPLICATIONS (JANUARY 2012-DECEMBER 2022)
5.9 ECOSYSTEM ANALYSIS
TABLE 9 MARKET: SUPPLY CHAIN ECOSYSTEM
5.10 KEY CONFERENCES AND EVENTS, 2023-2024
TABLE 10 MARKET: CONFERENCES AND EVENTS (2023−2024)
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STERILITY TESTING PRODUCTS
5.11.2 MARKET: BUYING CRITERIA
FIGURE 21 KEY BUYING CRITERIA FOR END USERS
5.12 TRADE ANALYSIS
TABLE 11 TOP 10 IMPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)
TABLE 12 TOP 10 EXPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)

6 STERILITY TESTING MARKET, BY PRODUCT & SERVICE (Page No. - 68)
6.1 INTRODUCTION
TABLE 13 MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
6.2 KITS & REAGENTS
6.2.1 RISING DEMAND FOR STANDARD STERILITY TESTING TO DRIVE MARKET
TABLE 14 MARKET FOR KITS & REAGENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 15 NORTH AMERICA: MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 16 EUROPE: MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 17 ASIA: MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 18 REST OF THE WORLD: MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 SERVICES
6.3.1 GROWING TREND OF OUTSOURCING SERVICES TO CROS TO DRIVE MARKET
TABLE 19 MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
TABLE 20 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 21 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 ASIA: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 23 REST OF THE WORLD: MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 INSTRUMENTS
6.4.1 INCREASING ADOPTION OF RAPID MICROBIAL METHODS TO SUPPORT MARKET GROWTH
TABLE 24 MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 25 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 26 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 27 ASIA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 REST OF THE WORLD: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)

7 STERILITY TESTING MARKET, BY TEST TYPE (Page No. - 76)
7.1 INTRODUCTION
TABLE 29 MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
7.2 MEMBRANE FILTRATION
7.2.1 RISING DEMAND FOR TESTING OF DRUGS IN LIQUID DOSAGE FORMS TO FUEL ADOPTION
TABLE 30 MARKET FOR MEMBRANE FILTRATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 31 NORTH AMERICA: MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 32 EUROPE: MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 33 ASIA: MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 REST OF THE WORLD: MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 DIRECT INOCULATION
7.3.1 ABILITY TO PROVIDE TESTING FOR MICROBIAL CONTAMINANTS TO DRIVE MARKET
TABLE 35 MARKET FOR DIRECT INOCULATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 36 NORTH AMERICA: MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 EUROPE: MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 38 ASIA: MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 39 REST OF THE WORLD: MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 OTHER TEST TYPES
TABLE 40 MARKET FOR OTHER TEST TYPES, BY REGION, 2021-2028 (USD MILLION)
TABLE 41 NORTH AMERICA: MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 EUROPE: MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 ASIA: MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 REST OF THE WORLD: MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)

8 STERILITY TESTING MARKET, BY APPLICATION (Page No. - 84)
8.1 INTRODUCTION
TABLE 45 MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOLOGICS MANUFACTURING
8.2.1 GROWING PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO DRIVE MARKET
TABLE 46 MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
TABLE 47 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 48 EUROPE: MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 ASIA: MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 50 REST OF THE WORLD: MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 MEDICAL DEVICE MANUFACTURING
8.3.1 RISING DEMAND FOR STERILITY TESTING OF MEDICAL DEVICES TO DRIVE MARKET
TABLE 51 MARKET FOR MEDICAL DEVICE MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 53 EUROPE: MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 ASIA: MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 REST OF THE WORLD: MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 56 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
TABLE 57 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 58 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 ASIA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 REST OF THE WORLD: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 STERILITY TESTING MARKET, BY END USER (Page No. - 93)
9.1 INTRODUCTION
TABLE 61 MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2 PHARMACEUTICAL COMPANIES
9.2.1 GROWING EXPANSION OF PRODUCTION CAPACITIES AND STRONG PIPELINE OF NOVEL DRUGS TO DRIVE MARKET
TABLE 62 MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 63 NORTH AMERICA: MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 EUROPE: MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 ASIA: MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 66 REST OF THE WORLD: MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 RISING R&D INVESTMENTS IN BIOTECH FIRMS TO DRIVE MARKET
TABLE 67 MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 68 NORTH AMERICA: MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 69 EUROPE: MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 70 ASIA: MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 REST OF THE WORLD: MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
9.4 OTHER END USERS
TABLE 72 MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 75 ASIA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 76 REST OF THE WORLD: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 STERILITY TESTING MARKET, BY REGION (Page No. - 101)
10.1 INTRODUCTION
TABLE 77 MARKET, BY REGION, 2021-2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: STERILITY TESTING MARKET SNAPSHOT
TABLE 78 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 79 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 80 NORTH AMERICA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.1 US
10.2.1.1 Rising growth in medical devices industry to fuel uptake
TABLE 83 US: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 84 US: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 85 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 86 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising demand for pharmaceutical & biologics manufacturing to support market growth
TABLE 87 CANADA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 88 CANADA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 89 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 90 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IaMPACT
10.3 EUROPE
TABLE 91 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 92 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 93 EUROPE: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 94 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 95 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Favorable R&D funding by federal & state governments to fuel uptake
TABLE 96 GERMANY: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 97 GERMANY: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 98 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 99 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising development of biotechnology manufacturing firms to drive market
TABLE 100 UK: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 101 UK: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 102 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 103 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising government initiatives for biologics manufacturing to support market growth
TABLE 104 FRANCE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 105 FRANCE: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABaLE 106 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 107 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Favorable government support for establishment of biotech startups to support market growth
TABLE 108 ITALY: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 109 ITALY: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 110 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 111 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing focus on development of APIs to fuel uptake
TABLE 112 SPAIN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 113 SPAIN: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 114 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 115 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 116 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 117 REST OF EUROPE: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 118 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 119 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA
FIGURE 23 ASIA: STERILITY TESTING MARKET SNAPSHOT
TABLE 120 ASIA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 121 ASIA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 122 ASIA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 123 ASIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 124 ASIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Favorable government policies to increase drug manufacturing to drive market
TABLE 125 CHINA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 126 CHINA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 127 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 128 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising investments for cell & gene therapy facilities to support market growth
TABLE 129 JAPAN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 130 JAPAN: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 131 JAPAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 132 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing demand for biosimilars to drive market
TABLE 133 INDIA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 134 INDIA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 135 INDIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 136 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Significant exports of pharmaceutical drugs to fuel uptake of sterility testing services
TABLE 137 SOUTH KOREA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 138 SOUTH KOREA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 139 SOUTH KOREA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 140 SOUTH KOREA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.5 REST OF ASIA
TABLE 141 REST OF ASIA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 142 REST OF ASIA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 143 REST OF ASIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 144 REST OF ASIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 145 REST OF THE WORLD: STERILITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 146 REST OF THE WORLD: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 147 REST OF THE WORLD: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 148 REST OF THE WORLD: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 149 REST OF THE WORLD: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.1 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN
10.5.1.1 Growing vaccine production to propel demand for sterility testing
TABLE 150 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 151 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 152 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 153 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.2 PACIFIC AND OCEANIA
10.5.2.1 Improving investments in pharmaceutical R&D to fuel uptake
TABLE 154 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 155 PACIFIC AND OCEANIA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 156 PACIFIC AND OCEANIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 157 PACIFIC AND OCEANIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.3 AFRICA
10.5.3.1 Favorable government support for healthcare infrastructure to drive market
TABLE 158 AFRICA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 159 AFRICA: MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
TABLE 160 AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 161 AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 144)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 162 STERILITY TESTING MARKET: KEY PLAYER STRATEGIES
11.3 MARKET SHARE ANALYSIS
FIGURE 24 MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2022 (LEADING FOUR COMPANIES)
TABLE 163 MARKET: INTENSITY OF COMPETITIVE RIVALRY
11.4 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 25 MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS (TOP FOUR)
11.5 COMPANY EVALUATION QUADRANT
FIGURE 26 MARKET: COMPANY EVALUATION MATRIX (2022)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
FIGURE 27 MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
11.7 COMPETITIVE BENCHMARKING
11.7.1 COMPANY PRODUCT FOOTPRINT
TABLE 164 MARKET: PRODUCT PORTFOLIO ANALYSIS
11.7.2 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 165 MARKET: GEOGRAPHIC ANALYSIS
11.8 COMPETITIVE SCENARIO
TABLE 166 MARKET: DEALS (JANUARY 2019−JANUARY 2023)
TABLE 167 MARKET: OTHER DEVELOPMENTS (JANUARY 2019−JANUARY 2023)

12 COMPANY PROFILES (Page No. - 156)
12.1 KEY PLAYERS
(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*
12.1.1 MERCK KGAA
TABLE 168 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2021)
12.1.2 CHARLES RIVER LABORATORIES
TABLE 169 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
FIGURE 29 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.3 BIOMÉRIEUX SA
TABLE 170 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 30 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
12.1.4 SGS S.A.
TABLE 171 SGS SA: BUSINESS OVERVIEW
FIGURE 31 SGS S.A.: COMPANY SNAPSHOT (2021)
12.1.5 SARTORIUS AG
TABLE 172 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022)
12.1.6 THERMO FISHER SCIENTIFIC INC.
TABLE 173 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
12.1.7 WUXI APPTEC
TABLE 174 WUXI APPTEC: BUSINESS OVERVIEW
12.1.8 SAMSUNG BIOLOGICS
TABLE 175 SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
FIGURE 34 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2021)
12.1.9 GENSCRIPT
TABLE 176 GENSCRIPT: BUSINESS OVERVIEW
FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2021)
12.1.10 PACIFIC BIOLABS
TABLE 177 PACIFIC BIOLABS: BUSINESS OVERVIEW
12.1.11 NELSON LABORATORIES, LLC
TABLE 178 NELSON LABORATORIES, LLC: BUSINESS OVERVIEW
* Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 PACE ANALYTICAL
12.2.2 RAPID MICRO BIOSYSTEMS, INC.
12.2.3 TENTAMUS
12.2.4 SINGOTA SOLUTIONS
12.2.5 NEOPHARM LABS INC.
12.2.6 LEXAMED
12.2.7 ASTELL SCIENTIFIC LTD
12.2.8 HIMEDIA LABORATORIES
12.2.9 PALL CORPORATION (PART OF DANAHER CORPORATION)
12.2.10 BOSTON ANALYTICAL
12.2.11 SOLVIAS AG
12.2.12 BD

13 APPENDIX (Page No. - 192)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS